Starkey M P, Compston-Garnett L, Malho P, Dunn K, Dubielzig R
Molecular Oncology Group, Animal Health Trust, Newmarket, UK.
Comparative Ophthalmology Unit, Animal Health Trust, Newmarket, UK.
Vet Comp Oncol. 2018 Mar;16(1):81-89. doi: 10.1111/vco.12315. Epub 2017 May 17.
Uveal melanoma (UM) is the most common primary intraocular tumour in dogs. There is no effective means of predicting whether a tumour will metastasize. microRNA (miRNA) metastasis signatures have been identified for several human cancers, including UM.
In this study we investigated whether metastasizing and non-metastasizing canine UMs can be distinguished by miRNA expression levels.
miRNA microarray profiling was used to compare miRNA expression in 8 metastasizing and 12 non-metastasizing formalin-fixed, paraffin-embedded (FFPE) primary UM biopsies.
Fourteen miRNAs exhibited statistically significant differences in expression between the metastasizing and non-metastasizing tumours. Class prediction analysis pinpointed 9 miRNAs which categorized tumours as metastasizing or non-metastasizing with an accuracy of 89%. Of the discriminating miRNAs, 8 were up-regulated in metastasizing UM, and included 3 miRNAs implicated as potential "metastasis activators" in human cutaneous melanoma. The expression of 4 of the miRNAs was subsequently measured using the quantitative reverse transcription polymerase chain reaction (RT-qPCR), and their up-regulation in metastasizing tumours validated.
miRNA expression profiles may potentially be used to identify UMs that will metastasize, and miRNAs that are up-regulated in metastasizing tumours may be targets for therapeutic intervention.
葡萄膜黑色素瘤(UM)是犬类最常见的原发性眼内肿瘤。目前尚无有效的方法来预测肿瘤是否会发生转移。包括UM在内,已为几种人类癌症鉴定出微小RNA(miRNA)转移特征。
在本研究中,我们调查了是否可以通过miRNA表达水平区分转移性和非转移性犬UM。
使用miRNA微阵列分析来比较8例转移性和12例非转移性福尔马林固定、石蜡包埋(FFPE)的原发性UM活检组织中的miRNA表达。
14种miRNA在转移性和非转移性肿瘤之间的表达存在统计学上的显著差异。分类预测分析确定了9种miRNA,其将肿瘤分类为转移性或非转移性的准确率为89%。在具有鉴别性的miRNA中,8种在转移性UM中上调,其中包括3种在人类皮肤黑色素瘤中被认为是潜在“转移激活剂”的miRNA。随后使用定量逆转录聚合酶链反应(RT-qPCR)测量了4种miRNA的表达,并验证了它们在转移性肿瘤中的上调。
miRNA表达谱可能潜在地用于识别会发生转移的UM,并且在转移性肿瘤中上调的miRNA可能是治疗干预的靶点。